Measuring severe plaque psoriasis before and after new treatment
Part of Skin clinical trials.
This study measures how severe your psoriasis is using skin exams, special skin imaging (dermoscopy), and quality-of-life questionnaires before and after you start a new treatment. It aims to see how well the treatment works and how it affects your daily life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 6 years of age or older
- Newly diagnosed with plaque psoriasis covering more than 10% of your body
- Planning to start a new systemic therapy (oral pill or biologic injection)
- Have at least one representative psoriasis plaque that can be photographed with a special skin microscope
- Stopped any previous systemic therapy at least 2–3 months before starting this study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a proactive approach (adjusting drug levels based on regular blood tests) versus the usual way of using biologics for psoriasis. It helps see if active monitoring can improve treatment while keeping you safe.
This trial tests a new medication, CBP-0276, to see if it improves psoriasis symptoms and quality of life. It is for people with moderate to severe plaque psoriasis who might need stronger treatment.
This study tests a new medicine (HS-20137) for moderate-to-severe plaque psoriasis, a condition causing thick, scaly patches on the skin. It aims to see if this medicine can safely reduce the severity of psoriasis and improve quality of life.
This trial tests a new oral medication, CS32582, for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective at reducing skin symptoms like redness, thickness, and scaling.
This study tests an investigational medicine (HS-20118) for people with moderate-to-severe plaque psoriasis. The goal is to see if the drug can safely and effectively reduce psoriasis symptoms and improve quality of life.
This trial tests an investigational drug, HB0017, in adults with moderate to severe plaque psoriasis. If you have had psoriasis for at least 6 months and have not used certain biologic treatments, you may be able to join.
Hear when a new Psoriasis Vulgaris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.